Literature DB >> 8094359

mRNA expression of growth factors in glomeruli from diabetic rats.

T Nakamura1, M Fukui, I Ebihara, S Osada, I Nagaoka, Y Tomino, H Koide.   

Abstract

Evaluations of glomerular mRNA levels encoding for PCNA, TNF-alpha, PDGF-A and -B chains, TGF-beta, IGF-I, bFGF, and EGF were made at 4, 12, and 24 wk after injection of STZ in Sprague-Dawley rats. The mRNA levels for PCNA, TNF-alpha, PDGF-B chain, TGF-beta, and bFGF increased with age in STZ-induced diabetic rats. At 24 wk after STZ injection, mRNA levels for PCNA, TNF-alpha, PDGF-B chain, TGF-beta, and bFGF were increased 3.8-fold, (P < 0.01), 4.2-fold (P < 0.01), 4.0-fold (P < 0.01), 5.2-fold (P < 0.001), and 3.6-fold (P < 0.01), respectively, in the glomeruli of diabetic rats when compared with control rats. In contrast, mRNA levels for IGF-I, PDGF-A chain, and EGF were not altered in glomeruli from diabetic and control rats throughout the experimental period. Insulin treatment partially ameliorated the increase in mRNA levels for PCNA, TNF-alpha, PDGF-B chain, TGF-beta, and bFGF in the glomeruli of diabetic rats. These data indicate that alterations in growth factor mRNA levels in glomeruli may be a manifestation of diabetic nephropathy, and that hyperglycemia or insulin deficiency may play a role in abnormal growth factor gene regulation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094359     DOI: 10.2337/diab.42.3.450

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  51 in total

Review 1.  Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.

Authors:  G Pugliese; F Pricci; G Romeo; G Leto; L Amadio; C Iacobini; U Di Mario
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

2.  Deletion of platelet-derived growth factor receptor-β improves diabetic nephropathy in Ca²⁺/calmodulin-dependent protein kinase IIα (Thr286Asp) transgenic mice.

Authors:  H Suzuki; I Usui; I Kato; T Oya; Y Kanatani; Y Yamazaki; S Fujisaka; S Senda; Y Ishii; M Urakaze; A Mahmood; S Takasawa; H Okamoto; M Kobayashi; K Tobe; M Sasahara
Journal:  Diabetologia       Date:  2011-08-11       Impact factor: 10.122

Review 3.  Inflammation and diabetic nephropathy.

Authors:  Carmen Mora; Juan F Navarro
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

Review 4.  Uric acid as a mediator of diabetic nephropathy.

Authors:  Diana I Jalal; David M Maahs; Peter Hovind; Takahiko Nakagawa
Journal:  Semin Nephrol       Date:  2011-09       Impact factor: 5.299

5.  Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes.

Authors:  Alaa S Awad; Michael D Rouse; Konstantine Khutsishvili; Liping Huang; W Kline Bolton; Kevin R Lynch; Mark D Okusa
Journal:  Kidney Int       Date:  2011-02-02       Impact factor: 10.612

6.  CCN3: a novel anti-fibrotic treatment in end-stage renal disease?

Authors:  Andrew Leask
Journal:  J Cell Commun Signal       Date:  2012-03-16       Impact factor: 5.782

Review 7.  Diabetic complications and dysregulated innate immunity.

Authors:  Dana T Graves; Rayyan A Kayal
Journal:  Front Biosci       Date:  2008-01-01

8.  Increased activity of the insulin-like growth factor system in mesangial cells cultured in high glucose conditions. Relation to glucose-enhanced extracellular matrix production.

Authors:  G Pugliese; F Pricci; N Locuratolo; G Romeo; G Romano; S Giannini; B Cresci; G Galli; C M Rotella; U Di Mario
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

Review 9.  Proinsulin C-peptide: friend or foe in the development of diabetes-associated complications?

Authors:  Lina Nordquist; M Johansson
Journal:  Vasc Health Risk Manag       Date:  2008

10.  Lack of type VIII collagen in mice ameliorates diabetic nephropathy.

Authors:  Ulrike Hopfer; Helmut Hopfer; Catherine Meyer-Schwesinger; Ivonne Loeffler; Naomi Fukai; Bjorn R Olsen; Rolf A K Stahl; Gunter Wolf
Journal:  Diabetes       Date:  2009-04-28       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.